132 related articles for article (PubMed ID: 22844077)
1. In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling.
Paini A; Punt A; Scholz G; Gremaud E; Spenkelink B; Alink G; Schilter B; van Bladeren PJ; Rietjens IM
Mutagenesis; 2012 Nov; 27(6):653-63. PubMed ID: 22844077
[TBL] [Abstract][Full Text] [Related]
2. A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes.
Paini A; Punt A; Viton F; Scholz G; Delatour T; Marin-Kuan M; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2010 May; 245(1):57-66. PubMed ID: 20144636
[TBL] [Abstract][Full Text] [Related]
3. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect.
Alhusainy W; Paini A; Punt A; Louisse J; Spenkelink A; Vervoort J; Delatour T; Scholz G; Schilter B; Adams T; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2010 Jun; 245(2):179-90. PubMed ID: 20226806
[TBL] [Abstract][Full Text] [Related]
4. In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin.
Alhusainy W; Paini A; van den Berg JH; Punt A; Scholz G; Schilter B; van Bladeren PJ; Taylor S; Adams TB; Rietjens IM
Mol Nutr Food Res; 2013 Nov; 57(11):1969-78. PubMed ID: 23894034
[TBL] [Abstract][Full Text] [Related]
5. A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat.
Punt A; Freidig AP; Delatour T; Scholz G; Boersma MG; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2008 Sep; 231(2):248-59. PubMed ID: 18539307
[TBL] [Abstract][Full Text] [Related]
6. Detection and quantification of specific DNA adducts by liquid chromatography-tandem mass spectrometry in the livers of rats given estragole at the carcinogenic dose.
Ishii Y; Suzuki Y; Hibi D; Jin M; Fukuhara K; Umemura T; Nishikawa A
Chem Res Toxicol; 2011 Apr; 24(4):532-41. PubMed ID: 21384859
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of genotoxic mechanisms in estragole-induced hepatocarcinogenesis in rats.
Suzuki Y; Umemura T; Hibi D; Inoue T; Jin M; Ishii Y; Sakai H; Nohmi T; Yanai T; Nishikawa A; Ogawa K
Arch Toxicol; 2012 Oct; 86(10):1593-601. PubMed ID: 22576464
[TBL] [Abstract][Full Text] [Related]
8. NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice.
Bristol DW
Toxic Rep Ser; 2011 Jan; (82):1-111. PubMed ID: 21445103
[TBL] [Abstract][Full Text] [Related]
9. In vivo genotoxicity of estragole in male F344 rats.
Ding W; Levy DD; Bishop ME; Pearce MG; Davis KJ; Jeffrey AM; Duan JD; Williams GM; White GA; Lyn-Cook LE; Manjanatha MG
Environ Mol Mutagen; 2015 May; 56(4):356-65. PubMed ID: 25361439
[TBL] [Abstract][Full Text] [Related]
10. Estragole: DNA adduct formation in primary rat hepatocytes and genotoxic potential in HepG2-CYP1A2 cells.
Schulte-Hubbert R; Küpper JH; Thomas AD; Schrenk D
Toxicology; 2020 Nov; 444():152566. PubMed ID: 32853702
[TBL] [Abstract][Full Text] [Related]
11. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
Beland FA
Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
[TBL] [Abstract][Full Text] [Related]
12. Estragole DNA adduct accumulation in human liver HepaRG cells upon repeated in vitro exposure.
Yang S; Wesseling S; Rietjens IMCM
Toxicol Lett; 2021 Feb; 337():1-6. PubMed ID: 33189830
[TBL] [Abstract][Full Text] [Related]
13. Immunochemical identification of hepatic protein adducts derived from estragole.
Wakazono H; Gardner I; Eliasson E; Coughtrie MW; Kenna JG; Caldwell J
Chem Res Toxicol; 1998 Aug; 11(8):863-72. PubMed ID: 9705747
[TBL] [Abstract][Full Text] [Related]
14. Cellular levels and molecular dynamics simulations of estragole DNA adducts point at inefficient repair resulting from limited distortion of the double-stranded DNA helix.
Yang S; Diem M; Liu JDH; Wesseling S; Vervoort J; Oostenbrink C; Rietjens IMCM
Arch Toxicol; 2020 Apr; 94(4):1349-1365. PubMed ID: 32185416
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Interindividual Human Variation in Bioactivation and DNA Adduct Formation of Estragole in Liver Predicted by Physiologically Based Kinetic/Dynamic and Monte Carlo Modeling.
Punt A; Paini A; Spenkelink A; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2016 Apr; 29(4):659-68. PubMed ID: 26952143
[TBL] [Abstract][Full Text] [Related]
16. Matrix modulation of the bioactivation of estragole by constituents of different alkenylbenzene-containing herbs and spices and physiologically based biokinetic modeling of possible in vivo effects.
Alhusainy W; van den Berg SJ; Paini A; Campana A; Asselman M; Spenkelink A; Punt A; Scholz G; Schilter B; Adams TB; van Bladeren PJ; Rietjens IM
Toxicol Sci; 2012 Sep; 129(1):174-87. PubMed ID: 22649189
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
18. Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays.
Paini A; Scholz G; Marin-Kuan M; Schilter B; O'Brien J; van Bladeren PJ; Rietjens IM
Mutagenesis; 2011 Sep; 26(5):605-18. PubMed ID: 21642616
[TBL] [Abstract][Full Text] [Related]
19. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents.
Izzotti A; Camoirano A; Cartiglia C; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
Cancer Res; 1999 Sep; 59(17):4285-90. PubMed ID: 10485473
[TBL] [Abstract][Full Text] [Related]
20. DNA damage and DNA adduct formation in rat tissues following oral administration of acrylamide.
Manière I; Godard T; Doerge DR; Churchwell MI; Guffroy M; Laurentie M; Poul JM
Mutat Res; 2005 Feb; 580(1-2):119-29. PubMed ID: 15668114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
